SureTrader
Home > Boards > US Listed > Medical - Drugs > Oramed Pharmaceuticals (ORMP)

Been following this one for a couple of

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
humpback Member Profile
 
Followed By 8
Posts 1,591
Boards Moderated 0
Alias Born 04/09/07
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 2/20/2018 2:05:43 PM
Oramed to Present at the CODHy 6th World Congress on Diabetes, Obesity and Hypertension PR Newswire (US) - 2/20/2018 8:25:00 AM
Oramed to Present at BIO CEO Investor Conference PR Newswire (US) - 2/6/2018 8:25:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/2/2018 5:37:41 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/2/2018 5:35:57 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/2/2018 5:33:46 PM
Oramed Pharmaceuticals' CEO Issues Letter to Shareholders PR Newswire (US) - 1/19/2018 8:25:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 1/11/2018 1:11:03 PM
Annual Report (10-k) Edgar (US Regulatory) - 11/29/2017 5:26:27 PM
Oramed Receives Regulatory Approval to Conduct Clinical Study for Treatment of NASH with its Oral Insulin Capsule PR Newswire (US) - 11/14/2017 8:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(7) (424b7) Edgar (US Regulatory) - 11/3/2017 6:05:42 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/1/2017 4:41:20 PM
Oramed Granted Broad Composition of Matter Patent in Europe for Oral Proteins PR Newswire (US) - 10/31/2017 8:35:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/25/2017 4:37:14 PM
Oramed to Present at the Diabetes Technology Meeting PR Newswire (US) - 10/24/2017 9:25:00 AM
Endocrinology, Diabetes and Metabolism Journal Publishes Scientific Paper Authored by Oramed Scientists PR Newswire (US) - 10/17/2017 8:40:00 AM
Prospectus Filed Pursuant to Rule 424(b)(7) (424b7) Edgar (US Regulatory) - 10/16/2017 5:23:01 PM
Oramed to Present at the Disruptive Growth Showcase Conference PR Newswire (US) - 9/25/2017 8:55:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/5/2017 4:01:56 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/5/2017 2:49:14 PM
Oramed Announces Successful Meeting with FDA for Oral Insulin PR Newswire (US) - 9/5/2017 6:00:00 AM
Oramed to Present at the Rodman & Renshaw Global Investment Conference PR Newswire (US) - 8/29/2017 8:50:00 AM
Prospectus Filed Pursuant to Rule 424(b)(7) (424b7) Edgar (US Regulatory) - 8/28/2017 3:54:30 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/21/2017 1:57:18 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/17/2017 4:24:16 PM
humpback   Friday, 10/31/08 03:01:57 PM
Re: axelvento post# 61
Post # of 509 
Been following this one for a couple of years now. Just bought back in. Do you think that this company has a chance to be bought out by a larger pharmaceutical company?

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist